A. Shaw
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 13
- Lung Cancer Diagnosis and Treatment 2
- Oncology 8
- Lung Cancer Research Studies 6
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Ellen M. Gravallese (3 shared papers)Benjamin Solomon (4 shared papers)D. Ross Camidge (6 shared papers)A. John Iafrate (3 shared papers)Yukiko Maeda (2 shared papers)S.‐H.I. Ou (1 shared paper)Jin Seok Ahn (1 shared paper)M. Pérol (2 shared papers)
- Journals
- Annals of Oncology (6 papers)Clinical Pharmacology & Therapeutics (2 papers)Scandinavian Journal of Rheumatology (2 papers)Clinical Cancer Research (1 paper)Immunologic Research (1 paper)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
A. Shaw
18 papers receiving 1.1k citations
A. Shaw's Hit Papers
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 740
- Oncology 458
- Cancer Research 169
- Rheumatology 104
- Molecular Biology 329
Countries citing papers authored by A. Shaw
This map shows the geographic impact of A. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Shaw more than expected).
Fields of papers citing papers by A. Shaw
This network shows the impact of papers produced by A. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Shaw. The network helps show where A. Shaw may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Shaw, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study Hit paper breakdown → | 2020 | 429 |
| 2 | Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Hit paper breakdown → | 2019 | 379 |
| 3 | 2015 | 76 | |
| 4 | 2016 | 75 | |
| 5 | 2013 | 73 | |
| 6 | 2016 | 27 | |
| 7 | 2013 | 18 | |
| 8 | 2012 | 16 | |
| 9 | 2017 | 13 | |
| 10 | 2010 | 10 | |
| 11 | 2011 | 9 | |
| 12 | 2009 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2019 | 2 | |
| 16 | 2025 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2013 | 1 |
About A. Shaw
A. Shaw is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Genetics, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (740 citations), Oncology (458 citations), Cancer Research (169 citations), Rheumatology (104 citations) and Molecular Biology (329 citations). A. Shaw has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Ellen M. Gravallese, Benjamin Solomon, D. Ross Camidge, A. John Iafrate, Yukiko Maeda, S.‐H.I. Ou, Jin Seok Ahn, M. Pérol, Donghyeon Kim and Thorsten Ruf. Their work appears in journals such as Annals of Oncology, Clinical Pharmacology & Therapeutics, Scandinavian Journal of Rheumatology, Clinical Cancer Research and Immunologic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.